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ABSTRACT 
 
The expression of extracellular matrix (ECM) specific receptors, integrins, was 
investigated in two closely related strains of oncogenically transformed fibroblasts 
drastically differing in spontaneous metastasizing. The highly metastatic cells (HM) were 
shown to express in their surface membranes much higher levels of collagen/vitronectin-
specific integrin αvβ3, as compared to their lowly metastatic counterparts (LM). Inhibition 
of the αvβ3-mediated signal transduction strongly reduced the in vitro invasiveness of 
HM, whereas stimulation of αvβ3 signaling markedly augmented their invasive activity. 
The data obtained provide a direct evidence for implication of αvβ3 integrin in invasive 
phenotype of the oncotransformed fibroblasts. 
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INTRODUCTION 
 
Tumor cell invasion and metastasis is a 
multistep process involving numerous cell-
cell and cell-extracellular matrix 
associations. Cell interaction with the 
matrix proteins is mediated through cell 
surface receptors, of which the best studied 
are integrins. They are composed of two 
non-covalently associated α and β subunits 
and the combination of 8 β subunits with at 
least 14 α subunits generates a 
heterogeneous family of over 20 
heterodimers (Eble 1997; Humphries 2000). 
It was initially thought that integrins 
function merely as linkers between the cells 
and the ECM, but in recent years it has 
become evident that integrins can transduce 
signals controlling various aspects of  cell 
behavior, such as  migration, differentiation 
and apoptosis (Brakebusch et al. 2002; 
Berman et al. 2003). 
 
Both of these functions of integrins suggest 
their involvement in the mechanisms of 
tumor growth and progression (Heino 1996; 
Hood and Cheresh 2002). But the data from 
various reports appear to be conflicting. In 
particular, a positive correlation, which was 
found in some studies between the 
expression of distinct integrins and 
metastatic capacity of tumor cells has not 
been observed in other investigations 
(Keely et al. 1998; Berman and Kozlova 
2000; Hood and Cheresh 2002). 
 
One reason that might account for these 
discrepancies is that the majority of 
published studies have been conducted on 
epithelial cells which are characterized by a 
high diversity of integrins. Any matrix 
protein can bind more than one receptor and 
individual integrins can recognize more 
than one matrix protein. This implies that 
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attachment of a cell to a substrate would 
remain unchanged if reduced expression of 
one integrin is compensated by enhanced 
expression of another receptor having the 
same substrate binding specificity. 
Likewise, reduced signal transduction, 
caused by a decreased expression of one 
integrin, may be compensated by another 
receptor, generating the similar signal. On 
the other hand, two integrins that bind the 
same ligand can induce distinct cellular 
responses (Heino 1996; Berman et al. 
2003). Therefore, availability of cell lines, 
differing in metastatic activity while 
exposing limited patterns of integrins, will 
facilitate the definition of the role of a 
particular receptor. 
 
We have previously shown that two strains 
of Rous sarcoma virus transformed Syrian 
hamster fibroblasts, differing in 
spontaneous metastasizing, have a restricted 
spectrum of integrins exposed on their 
surface membranes (Kozlova et al. 1997). 
In this study we have shown for the first 
time that invasive phenotype of the embryo 
fibroblasts with high metastatic activity 
may be accounted for by increased 
expression and signaling of the 
collagen/vitronectin-specific integrin αvβ3.
 
MATERIALS AND METHODS 
 
Chemicals 
Polyclonal antibodies against the 
cytodomain of α5 integrin subunit and 
monoconal antibody LM609 to the αvβ3 
dimer were purchased from Chemicon 
(USA). Matrigel, oligopeptides Gly-Arg-
Gly-Asp-Ser (GRGDS) and Gly-Arg-Glu-
Ser (GRES) as well as N-
hydroxysuccinimidobiotin amidocaproate 
(NHS-biotin) were from Sigma (USA). 
Oligonucleotides were synthesized by 
Syntol (Мoscow). Reagents for reverse 
transcription and polymerase chain reaction 
(RT-PCR) were obtained from Invitrogen 
(USA). 
 
 
Cells 
The parental strain of Rous sarcoma virus 
(RSV) transformed Syrian hamster 
fibroblasts with a low level of spontaneous 
metastasizing (lowly metastatic cells, LM) 
and its highly metastatic derivative (HM), 
were obtained from Russian Cancer Center 
(Moscow). The cells were propagated in 
DMEM supplemented with 5% fetal calf 
serum, 2 mM L-glutamine, 100 U/ml 
penicillin and 100 µg/ml streptomycin. 
 
Cell adhesion 
Cell adhesion to ECM proteins was assayed 
as described (Berman et al. 1993). 96-well 
microtiter plates were coated with 10 µg/ml 
substrate proteins, and free sites were 
blocked with 5 mg/ml bovine serum protein 
(BSA). Cells (7x104 in 100 µl of serum free 
DMEM, containing 2.5 mg/ml BSA) were 
seeded in the plates and incubated at 370C 
for 1 hr. Non-adherent cells were washed 
off, and the number of adhered cells was 
assessed in a hexosaminidase reaction 
(Erokhina et al. 1994). 
 
Biotinylation 
Biotinylation of cell surface proteins, 
immunoprecipitation of integrins, 
electrophoresis, and Western-blotting were 
performed as described (Kozlova et al. 
1997). Cells (1x107) in PBS (1 ml) were 
biotinylated with NHS-biotin (100 µg/ml, 
30 min., 200), washed and lysed in 
extraction buffer (25 mM tris-HCl, pH 7.5, 
containing 100 mM octylglucoside, 2.5 mM 
MgCl2, 2.5 mM MnCl2, 10-3 M 
phenylmethanesulfonic acid, and 10 µg/ml 
of leupeptin). After centrifugation (15000 g, 
20 min.) the biotin content in the extracts 
was determined by ELISA with avidin-
peroxidase conjugate. Cell extracts (1 ml) 
of equal biotin contents were incubated 
with 25 µl of anti-integrin antibodies 
overnight at 40C and immunoprecipitates 
were bound to Protein A-agarose. The 
precipitates were heat-denatured under non-
reducing conditions, separated by 7.5% 
SDS-PAGE, and transferred to 
nitrocellulose membrane. Blots were 
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developed with Enhanced 
Сhemiluminescence System (ECL; 
Amersham, UK) 
 
In vitro invasion 
In vitro invasion was assayed in transwells 
(Costar, membrane diameter 6.5-mm, pore 
size 8 µm). The upper chamber was filled 
with 50 µl of a solution of Matrigel (3 
mg/ml) in DMEM and incubated for 2 hr at 
37°C to let the gel forms. Cells (2 x 104) in 
200-300 µl of the same medium containing 
0.5% fetal serum were seeded on the gel, 
and the lower chamber was filled with 1 ml 
of the medium. The wells were incubated at 
37°C for 24 hr, and then the number of the 
cells migrated into the lower chamber was 
determined. In experiments with an RGD 
containing peptide (Gly-Arg-Gly-Asp-Ser), 
control peptide Arg-Gly-Glu-Ser (RGE 
peptide) (500 µg/ml each), cells were 
incubated with these agents for 30 min. and 
then placed in the top chamber for the 
invasion assay. 
 
Stimulation of integrin signaling 
Plastic dishes were coated with 25 µg/ml 
rabbit anti–mouse IgG at 370C for 2 hr, 
followed by blocking with 1% heat-
denatured BSA at 370C for 1 hr. Then, anti-
αvβ3 antibody LM 609 or mouse IgG (each 
10 µg/ml) were allowed to bind the 
immobilized anti–mouse IgG for 14 hr at 
40C. Subconfluent HM fibroblasts were 
suspended in serum free DMEM and 
allowed to attach to antibody-coated dishes 
for 4 hr at 370C. Cells were then processed 
for in vitro invasion assay as described 
above. 
 
Reverse transcription-polymerase chain 
reaction (RT-PCR) 
Isolation of total cellular RNA and RT were 
described earlier (Kozlova et al. 2001). As 
was evidenced by agarose gel 
electrophoresis no visible traces of high 
molecular DNA were found in the RNA 
preparations. Primer sequences for PCR 
were the following: αv subunit: 5'-
GTTGGGAGATTAGACAGAGGA-3' 
(sense), 5' 
CAAAACAGCCAGTAGCAACAA-3' 
(antisense); β-actin: 5'-
GTGGGGCGCCCCAGGCACCA-3' 
(sense), 5'-
CTCCTTAATGTCACGCACGATTTC-3' 
(antisense). Denaturing was performed at 
940C, elongation at 720C, annealing at 560C 
(for αv) and 600C (for β-actin) (internal 
standard). The optimal numbers of PCR 
cycles were 40 for αv and 22 for β-actin. 
The primers used for cDNA amplification 
are the sequences located at different exons 
of the respective genes, separated by one or 
more introns. Therefore, if genomic DNA 
contaminations were present in RT 
preparations, the PCR products amplified 
from these DNA would be of much higher 
molecular sizes than those synthesized from 
the target cDNA. In our experiments, only 
bands with the expected sizes, 
corresponding to target cDNAs, were seen 
in agarose gel electrophoresis. 
 
Statistical analysis 
Statistical analysis was carried out using 
Student’ s t-test. Differences between 
groups with p<0.05 were considered 
statistically significant. 
 
 
RESULTS AND DISCUSSION 
 
We first addressed the question of whether 
there are any differences between LM and 
HM cells in their adhesion to the matrix 
proteins. As seen in Fig.1, both cell types 
demonstrated virtually equal attachment to 
native type I collagen, fibronectin and 
laminin. In contrast to these substrates, 
heat-denatured type I collagen appeared to 
support the attachment of HM fibroblasts 
much stronger than of LM cells.
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Figure 1: Adhesion of lowly and highly metastatic fibroblasts (LM and HM resp.) to 
matrix proteins. Cell attachment to matrix proteins was quantified as described in 
“Materials and methods”. Col, type I native collagen; dCol, type I denatured 
collagen; FN, fibronectin; LN, laminin. Data are mean ± s.e.m. of 3 experiments, 
each performed in triplicate. *p< 0.01 compared with HM cells adhered to dCol. 
 
Denatured collagen is known to be a 
specific adhesion substrate for αvβ3 
integrin (Eble 1997). Therefore, the 
observed differences in adhesive properties 
suggested that the expression of αvβ3 could 
be altered in HM cells. 
 
To test this suggestion, the LM and HM 
fibroblasts were compared for their cell 
surface expression of integrins. Western 
bloting data, presented in Fig. 2a, 
demonstrate that the HM fibroblasts are 
much more active in surface expression of 
the collagen/vitronectin-specific αvβ3 
receptor. In contrast, HM cells expressed 
markedly lower amount of α5β1 integrin, 
the fibronectin-specific receptor, than LM 
fibroblasts. These data corroborate the 
results of adhesion assay. 
 
Data on cell surface expression of integrins 
were supported by RT-PCR analysis that 
revealed the reduced αv mRNA in LM 
compared with HM cells (Fig. 2b). 
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Figure 2: Integrin expression in lowly metastatic (1) and highly metastatic (2) 
fibroblasts. (a) Cell surface expression of integrins. Biotinylated cell surface 
proteins (see ‘Materials and Methods’) were precipitated with anti-integrin 
antibodies, separated in PAGE and transferred onto a nitrocellulose membrane. 
Blots were processed as indicated in “Materials and Methods. Right, sizes of 
molecular weight markers are indicated; left, positions of respective integrin 
subunits are indicated. (b) RT-PCR analysis of expression of αv mRNA. 
Expression of β-actin mRNA was used as an internal control. Right, sizes of 
respective PCR products are indicated. 
 
Invasiveness of lowly and highly metastatic 
fibroblasts 
The initial metastasis stages involve the 
destruction of surrounding tissue by tumor 
cells and their migration (invasion) from 
the primary loci across the basement 
membrane (Brakebusch et al. 2002; 
Egeblad and Werb 2002). An in vitro model 
reproducing this process is cell penetration 
and destruction of a gel formed by gelation 
of matrix proteins, Matrigel (Heino 1996). 
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Figure 3: In vitro invasion of lowly and highly metastatic fibroblasts. 2·104  cells 
were plated into the upper chamber of a transwell, incubated 24 hr at 370C and the 
number of cells in the lower chamber was determined. Data are mean ± s.e.m. of 
three independent experiments. * p < 0.05 relative to LM. 
 
Figure 3 demonstrates that the highly 
metastatic fibroblasts are much more active 
in invasion through Matrigel compared to 
parent lowly metastatic cells. 
 
We next addressed whether elevated 
expression of the αvβ3 integrin in highly 
metastatic cells is associated with their 
invasion phenotype. We explored two 
approaches. First, we assessed the effect of 
an RGD containing peptide known to 
antagonize integrin mediated signaling 
(Ruoslahti 1996) on invasiveness of RSV-
transformed fibroblasts. 
 
Figure 4 demonstrates that treatment of HM 
fibroblasts with the RGD-containig peptide 
resulted in a 10-fold decrease of their 
invasion through Matrigel while the control 
RGE peptide was ineffective. In contrast, 
treatment of LM fibroblasts with the RGD 
peptide had an insignificant effect on 
invasion. As seen in Fig. 2, LM cells are 
active in the expression of α5β1 integrin, 
unlike the HM fibroblasts exhibiting a high 
level of αvβ3 expression. Both of these 
receptors are RGD-dependent and can be 
modulated by RGD peptides (Brassard et al. 
1999). However, only the αvβ3-expressing 
fibroblasts reduced their invasive activity 
upon treatment with the RGD peptide. This 
finding emphasizes an important role of the 
αvβ3 integrin in invasiveness of HM 
fibroblasts. Lack of this integrin on LM 
cells is likely to make them resistant to the 
RGD peptide. 
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Figure 4: Effect of RGD-peptide on invasiveness of highly and lowly metastatic 
fibroblasts. 2·104  cells treated with RGES or GRGDS (see “Materials and 
Methods”) were plated into the upper chamber of a transwell, incubated 24 hr at 
370C and the number of cells migrated into the lower chamber was determined. 
Data are mean ± s.e.m. of three independent experiments. * p < 0.01 relative to 
HM treated with RGES. 
 
Second approach is based on the ability of 
integrins, ligated by anti-integrin 
antibodies, to mediate signal transduction 
and thereby modulate cell behaviour 
(Leavesley et al. 1993). 
 
Таble 1: Activation of αvβ3 integrin signaling stimulates the in vitro invasion of 
highly metastatic cells. 
  
                  Treatment                                              Invasion, % Control 
                 None (Control)                                           100 
                 Mouse IgG                                                 110 ± 11 
                 Anti-αvβ3                                                   159 ± 16 *
 
Cells were treated with mouse IgG or anti-αvβ3 antibody  LM 609 and assayed for 
the in vitro invasion as described in “Materials and Methods”. Data are mean ± 
s.e.m. of three independent experiments. * p < 0.05 relative Control and mouse 
IgG. 
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To examine whether ligation of αvβ3 
influences invasion of tumor cells, HM 
fibroblasts were plated on a substrate 
consisting of immobilized mouse IgG or 
anti-αvβ3 antibodies. Table 1 clearly shows 
that activation of αvβ3-mediated signaling 
markedly increased the invasive activity of 
HM cells whereas treatment with mouse 
IgG had no effect. This finding confirms 
the experiments with the RGD peptide. 
 
Data concerning the role of the αvβ3 
integrin in malignancy are ambiguous. In 
some reports, the important role of this 
receptor in invasion and metastasis was 
emphasized based on its elevated 
expression in a number of tumor-derived 
lines with high metastatic activity: cervical 
cancer (Chatterjee et al. 2001), 
hepatocellular carcinoma (Nejjari et al. 
2002), etc. These findings corroborate the 
results demonstrating that the in vivo 
administered αvβ3 antagonists strongly 
decreased dissemination of metastases and 
increased survival of animals (Reinmuth et 
al. 2003.; Kumar 2003). But these 
observations are not in line with the report 
that no overexpression of αvβ3 was found 
in the actively metastasizing stomach 
carcinoma cells (Yasoshima et al. 1996) 
and, moreover, re-expression of this 
receptor in a line of the αvβ3-deficient 
highly metastatic cells attenuated 
experimental metastasizing (Danen et al. 
1996). 
 
Similar contradictions were reported for 
expression of α5β1 and α6β4 integrins by 
tumor cells (Hood and Cheresh 2002; 
Clezardin 1998; Danen et al. 1996; Yao et 
al. 1997; Kawashima et al. 2001). 
 
In this study, a strong correlation was 
documented between the expression of 
collagen-specific integrin αvβ3, metastatic 
and invasive activity of oncotransformed 
fibroblasts and their affinity to denatured 
collagen. On the other hand, we have 
recently demonstrated that upon acquisition 
of multidrug resistance, breast carcinoma 
cells increased their invasive capacity 
which was accompanied by  a marked 
down-regulation of the αvβ3 receptor and 
dramatic up-regulation of integrin α5β1 
(Kozlova et al. 2004). One suggestion to 
reconcile these contradictions is that the 
acquisition of drug resistance may alter 
integrin-mediated signal transduction 
pathways. Another possibility is that during 
malignant evolution the breast carcinoma 
cells and oncotransformed fibroblasts were 
surrounded by different matrix proteins 
which induced each particular cell type to 
expose specific integrins on cell surface. 
Given that different integrins can transduce 
signals with similar physiological 
consequences (Boudreau and Jones 1999; 
Berman et al. 2003), one can assume that 
α5β1 in breast carcinoma cells and αvβ3 in 
transformed fibroblasts play a similar role 
in tumor progression. 
 
In conclusion, the data presented here and 
our previous results, as well as those 
reported by other authors, imply that each 
particular integrin can participate in 
establishment of particular phenotype 
depending on extracellular matrix content. 
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